Simple molecule could prevent, alleviate pre-diabetes

February 7, 2018, University of Sydney
insulin
High-resolution model of six insulin molecules assembled in a hexamer. Credit: Isaac Yonemoto/Wikipedia

Restoring levels of coenzyme Q10 (CoQ), a key molecule in energy production in cells, could overcome insulin resistance or pre-diabetes—a precursor to type 2 diabetes and cardiovascular disease.

Levels of CoQ and the presence of were analysed in a range of experimental laboratory settings, mouse models and samples from humans, as part of an ambitious research collaboration conducted with the University of Sydney, Victor Chang Cardiac Research Institute, Duke University School of Medicine, Garvan Institute of Medical Research, Genentech Inc. and the University of New South Wales.

Concentrations of CoQ were found to be lower in insulin resistant body fat and muscle tissue. When the researchers replenished CoQ, insulin resistance or pre-diabetes was reversed.

Co-author Dr Daniel Fazakerley from the University of Sydney's School of Life and Environmental Science and Charles Perkins Centre said CoQ provides a vital role in converting nutrients like fat and sugar into usable energy.

"CoQ is found in mitochondria, the power plants in the cells of our body, where it is required for the flow of electricity to the cell's 'motor' which is responsible for ," he explained.

"Energy production can also generate reactive chemical species - often referred to as 'reactive oxygen species' or 'oxidants' - as by-products, which can be damaging to cells.

"Previous studies have shown that these oxidants can cause insulin resistance. Our study has found that lower mitochondrial CoQ enhanced oxidant formation by mitochondria.

"Importantly, by replenishing CoQ in mitochondria, either in cells or in animals, we were able to restore 'normal' mitochondrial oxidants and reverse insulin resistance."

Published in eLife today, the research provides a missing link in our understanding of how changes in our diet can trigger insulin resistance, said co-lead author Professor David James, Leonard P. Ullmann Chair of Metabolic Systems Biology at the University of Sydney's Charles Perkins Centre.

"Eating a high fat, high sugar diet has long been known to be a major risk factor for obesity and pre-diabetes and our latest work brings us one step closer to understanding how and why," Professor James explained.

Co-lead author Professor Roland Stocker from the Victor Chang Cardiac Research Institute and the University of New South Wales added that the findings provide direction for potential future treatments for insulin resistance and pre-diabetes.

"Replenishing CoQ could prove an invaluable preventive measure for insulin resistance- or pre-diabetes-linked diseases such as type 2 diabetes, , cancers and dementia," he said.

"However, oral CoQ supplements may not effectively restore mitochondrial CoQ due to its low absorption," Professor Stocker explained.

"This work has provided an impetus for us to find alternate means of increasing CoQ in mitochondria to treat and pre-diabetes. If not an external supplement, perhaps we can stimulate the body to form more of the coenzyme itself - or find ways to prevent levels from lowering in the first place."

Explore further: Pre-diabetes discovery marks step towards precision medicine

More information: Daniel J Fazakerley et al, Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance, eLife (2018). DOI: 10.7554/eLife.32111

Related Stories

Pre-diabetes discovery marks step towards precision medicine

November 20, 2017
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection ...

Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

January 20, 2012
Excessive levels of certain saturated fatty acids cause mitochondria to fragment, leading to insulin resistance in skeletal muscle, a precursor of type 2 diabetes, according to a paper in the January issue of the journal ...

An increase in low density lipoproteins favors insulin resistance

October 24, 2017
A study led by the University of Barcelona has proved that low-density proteins (VLDL) can worsen insulin resistance, a disease that favours the development of type 2 diabetes. According to the researchers, these results, ...

A link between type 2 diabetes and mitochondrial function

October 1, 2013
Type 2 diabetes is a chronic condition that is characterized by resistance to or insufficient production of insulin, a hormone that controls sugar movement into cells. In certain tissues, insulin resistance has been associated ...

Research links fatty liver disease to type 2 diabetes

October 18, 2016
Insulin resistance in the liver is a major factor in the development of type 2 diabetes, and it is almost always associated with too much fat in the liver—a condition called non-alcoholic fatty liver disease (NAFLD). The ...

Gene could help explain insulin resistance

October 5, 2016
Health researchers have known for decades that type 2 diabetes results from a phenomenon called insulin resistance, but what causes insulin resistance has remained a mystery.

Recommended for you

Bariatric surgery successes lead to type 2 diabetes treatment

April 24, 2018
Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

Hacking human 'drug trafficking' network could make diabetes treatments more effective

April 23, 2018
Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

Vitamin D deficiency linked to greater risk of diabetes

April 19, 2018
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing ...

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

April 17, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

People with Type 2 diabetes who eat breakfast later, more likely to have a higher BMI

April 16, 2018
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic ...

Continuous glucose monitors proven cost-effective, add to quality of life for diabetics

April 12, 2018
Continuous glucose monitors (CGM) offer significant, daily benefits to people with type 1 diabetes, providing near-real time measurements of blood sugar levels, but they can be expensive. A new study by researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.